Literature DB >> 2506020

Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro.

I A Bakker-Woudenberg1, A F Lokerse, J C Vink-van den Berg, F H Roerdink.   

Abstract

The effect of free versus liposome-encapsulated muramyl dipeptide (MDP) on the uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro was investigated. Macrophages in monolayer culture were exposed to free MDP at various concentrations during different time periods before incubation with Listeria monocytogenes. An increase in bacterial uptake dependent on the concentration of MDP and the length of exposure was observed. Exposure of macrophages to 200 micrograms of free MDP per milliliter for 15 h led to a threefold increase in bacterial uptake, resulting in an average of 15 bacteria per macrophage after 30 min of incubation. In addition, intracellular bacteria were killed in the MDP-exposed macrophages, in contrast to the intracellular multiplication of Listeria monocytogenes in macrophages not exposed to MDP. Encapsulation of MDP within liposomes resulted in a significant enhancement of its activity: liposomal encapsulation led to a 1,000-fold reduction in the amount of MDP required to obtain these effects on bacterial uptake and intracellular killing, whereas empty liposomes had no effect at all. Liposomal encapsulation may be an appropriate means of increasing delivery of the muramyl peptides to the macrophages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506020     DOI: 10.1007/bf01968137

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

1.  Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages.

Authors:  I A Bakker-Woudenberg; A F Lokerse; J C Vink-van den Berg; F H Roerdink; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

2.  Uptake and intracellular processing of targeted and nontargeted liposomes by rat Kupffer cells in vivo and in vitro.

Authors:  G L Scherphof; J Dijkstra; H H Spanjer; J T Derksen; F H Roerdink
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

3.  The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitro.

Authors:  J W Hadden; A Englard; J R Sadlik; E M Hadden
Journal:  Int J Immunopharmacol       Date:  1979

4.  Protection of mice against fatal herpes simplex type 2 infection by liposomes containing muramyl tripeptide.

Authors:  W C Koff; S D Showalter; B Hampar; I J Fidler
Journal:  Science       Date:  1985-04-26       Impact factor: 47.728

5.  Strategies for potentiating chemotherapy in severe sepsis: some experimental pointers.

Authors:  F O'Grady
Journal:  J Antimicrob Chemother       Date:  1984-06       Impact factor: 5.790

6.  Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.

Authors:  N C Phillips; L Chedid
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

7.  Therapeutic efficacy of liposome-encapsulated ribavirin and muramyl tripeptide in experimental infection with influenza or herpes simplex virus.

Authors:  J D Gangemi; M Nachtigal; D Barnhart; L Krech; P Jani
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

8.  Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.

Authors:  Y Osada; M Mitsuyama; T Une; K Matsumoto; T Otani; M Satoh; H Ogawa; K Nomoto
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

9.  Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.

Authors:  N C Phillips; J Rioux; M S Tsao
Journal:  Hepatology       Date:  1988 Sep-Oct       Impact factor: 17.425

10.  Prophylaxis of murine candidiasis via application of liposome-encapsulated amphotericin B and a muramyl dipeptide analog, alone and in combination.

Authors:  R T Mehta; G Lopez-Berestein; R L Hopfer; K Mehta; R A White; R L Juliano
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

View more
  1 in total

1.  Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide in treatment of experimental Klebsiella pneumoniae infection.

Authors:  P M Melissen; W van Vianen; Y Rijsbergen; I A Bakker-Woudenberg
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.